Redona Therapeutics logo — We are explorers leading the revolution in RNA drug discover...

Redona Therapeutics

We are explorers leading the revolution in RNA drug discovery to develop an entirely new class of therapies.

Founded 2016 United States Watertown, United States 11 employees Series Unknown Total: $66.78M Health Care

General Information

Company Name Redona Therapeutics
Founded Year 2016
Location United States Watertown, United States +1
Employees 11
Industries Health Care
Funding Stage Series Unknown
Social

Get notified when Redona Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Redona Therapeutics

Redona Therapeutics is a pioneering company in the health care industry, aiming to revolutionize RNA drug discovery and develop groundbreaking therapies. Founded in 2016, the company is dedicated to the modulation of functional non-coding RNA (ncRNA) to combat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), Redona Therapeutics utilizes small molecules to modulate the expression levels of crucial proteins involved in diseases. The company recently received a significant $60.83M Venture Round investment on July 31, 2023, positioning it for further growth and advancements. With its headquarters in the United States, Redona Therapeutics stands as a notable player in the biotech industry, committed to reshaping the landscape of therapeutic solutions.

Taxonomy: RNA drug discovery, therapeutics, non-coding RNA, cancer treatment, small molecules, oncogenes, drug development, functional RNA modulation, oncology research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• - 31 Jul 2023
Venture Round •••••• - 31 Jul 2023
Venture Round •••••• 1
Investor
01 Jan 2019

Redona Therapeutics Alternatives & Competitors

Redona Therapeutics vs
Arraystar Inc.
Arraystar Inc. United States

Go Beyond RNA with us!

4 employees
Biotechnology
Redona Therapeutics vs

We unlock the therapeutic potentials of highly disease-relevant targets undruggable by small molecul...

Series A
31 employees
Biotechnology, Health Care
Redona Therapeutics vs
Ethris
Ethris Germany

Clinical stage biotech company focused on development of disruptive mRNA therapeutics for severe res...

Series Unknown
37 employees
Biopharma, Biotechnology

FAQ About Redona Therapeutics

We are explorers leading the revolution in RNA drug discovery to develop an entirely new class of therapies.
Redona Therapeutics was founded in 2016.
Redona Therapeutics is headquartered in Watertown, United States.
Redona Therapeutics operates in the following industries: Health Care.
Redona Therapeutics has approximately 11 employees.
Redona Therapeutics has completed 3 funding rounds, raising a total of $66.78M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Redona Therapeutics include Arraystar Inc., Rgenta Therapeutics Inc., Ethris, InSingulo AB, Remix Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Redona Therapeutics and Arraystar Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Redona Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy